Acetyl-L-carnitine
What is it: A targeted compound that enhances cellular energy and neuroprotectionAKA: ALCAR, L-acetylcarnitine- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
7 Resources
Referenced in this guide
5 Research papers
Referenced in this guide
7 Expert views
Contributed in this guide
30 Patient views
Contributed in this guide
Figure out what Acetyl-L-carnitine means for you
Page contents
Basics: What you need to know
Acetyl‐L‐carnitine (ALCAR) is a specialized form of L‐carnitine developed to enhance cellular energy production and support neurological function. It is rigorously tested under controlled dosages, focusing on its potential to aid individuals experiencing prolonged post-viral complications. While commonly recognized for bolstering mitochondrial health, it also has additional benefits such as supporting cognitive processes, nerve function, and mood regulation. Research has primarily centered on how its neuroprotective properties and its role in energy metabolism might benefit those with significant fatigue and brain fog. However, some individuals could experience gastrointestinal disturbances or heightened symptoms, making expert supervision important for proper dosing and safe use.
History and development
- Early interest: Carnitine’s role in energy production and fat metabolism was first identified in the early 1900s, setting the stage for further research on its variants.
- Modified structure: The acetylated version was developed in the mid-20th century by biochemists investigating ways to enhance the transport of carnitine into cells.
- Clinical focus: Researchers soon recognized ALCAR’s potential neurological benefits, spurring formal trials on its effects in neurodegenerative diseases.
- Refined protocols: More recent investigations standardized dosages and purity, elevating ALCAR from a generic supplement to a targeted therapeutic compound.
What is known
- Mitochondrial support: ALCAR helps transport fatty acids into mitochondria, boosting energy production and potentially reducing fatigue.
- Neuroprotective actions: It crosses the blood-brain barrier and has been linked to supporting neurotransmitter levels, which may help cognition.
- Mood benefits: Some studies highlight possible improvements in mood, especially in chronic post-viral conditions.
- Lesser-known effects: ALCAR might benefit nerve regeneration and speed nerve conduction, assisting in cases of neuropathy.
- Trigger warning: Certain individuals have reported an initial flare in symptoms due to metabolic shifts when first taking ALCAR.
What is not known
- Dose precision: The optimal dosage varies widely, and there is no definitive consensus on long-term administration strategies.
- Exact mechanics: While mitochondrial function is a main target, the precise biological steps linking ALCAR to symptom relief are still under investigation.
- Long-term safety: Large-scale, multi-year studies are still pending, leaving questions about how extended use may affect different organ systems.
- Broader interactions: ALCAR’s interplay with other post-viral treatments is not thoroughly understood, limiting guidance on combining therapies.
- Supports mitochondria: Facilitates fatty acid transport for enhanced energy production.
- Crosses blood-brain: Enables direct influence on neurotransmitter regulation.
- Acetylates molecules: Provides acetyl groups that may aid metabolic processes.
- Regulates signals: May stabilize nerve cell signaling for clearer cognitive function.
- Possible insomnia: Taking it too late in the day may disrupt sleep.
- Gastrointestinal upset: Nausea, cramping, or diarrhea can occur in sensitive individuals.
- Agitation risk: Rarely, it may cause mild irritability or restlessness.
- Headache episodes: Some report occasional headaches or tension pains.
- Varying results: Some individuals report noticeable benefits while others see limited changes.
- Dosage debates: Experts differ on ideal dosing strategies for maximum effect.
- quality control: Concerns arise about purity in non-regulated supplement markets.
- Individual tolerance: Some users experience side effects or symptom flare-ups early on.
Patient views
Experiences
- Patients appreciate the energy boost from Acetyl-L-carnitine (ALCAR).
- Many report improved brain fog and mental clarity.
- Some find it helps with post-exertional malaise (PEM).
- Affordable compared to other supplements.
Challenges
- Some experience side effects like muscle twitches or feeling wired.
- Benefits may diminish after reinfection or over time.
- Not effective for everyone; some see no improvement.
- Requires careful dosing to avoid fatigue or other issues.
Tips
- Pair ALCAR with other supplements like CoQ10 or NAC.
- Start with low doses and increase gradually.
- Take breaks to optimize performance and avoid fatigue.
- Monitor for side effects and adjust dosage as needed.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
I found NAC (600 mg daily) improved my brain fog. Going up to twice a day didn't make any immediate difference, but now after a week there may be a slight improvement. L-acetyl-carnitine has given me more energy. Started at 500mg daily and increased to 1000mg daily after a couple of weeks.
November 2024 • Turnto Comment
Patient view
As commented previously, NAC helped reduce brain fog. I recently added Acetyl-L-carnitine and it has given me energy - long may it last! I can't say that nattokinase has helped any, but I think a higher dose may be better. I'm trying to add things one at a time so I can assess the effect.
September 2024 • Turnto Comment
Expert views
What they liked
- Experts appreciate ALCAR's potential to boost energy levels.
- Some studies show slight improvements in fatigue symptoms.
- ALCAR may help muscle strength and energy in Long Covid patients.
- Experts value its role in supporting cellular energy production.
What they didn't like
- Experts note inconsistent results across different patient groups.
- Some studies show no significant improvement in symptoms.
- ALCAR's effectiveness varies widely among individuals.
- Experts caution against relying solely on ALCAR for recovery.
What are they unsure about
- Experts are uncertain about ALCAR's long-term effectiveness.
- Questions remain about its impact on cognitive dysfunction.
- Experts are unsure if ALCAR works for all Long Covid subtypes.
- More research is needed to confirm its benefits in muscle recovery.
7 expert views
Expert view
Dr. Wüst discusses the use of Acetyl-L-carnitine (ALCAR) supplementation for Long Covid, noting that some studies have shown slight improvements in energy levels, while others have not observed the same effects. He emphasizes that the efficacy of ALCAR may vary depending on individual patient populations and suggests that it could be worth trying on a case-by-case basis. Additionally, he mentions that certain foods might worsen symptoms, and removing them from the diet could help mitigate negative effects. Dr. Wüst also briefly touches on intermittent fasting as another potential approach.
October 2024 • Skeletal Muscle Fatigue & Post-Exertional Malaise in People w/Long Covid & Implications for ME/CFS
Expert view
The expert discussion highlights the use of supplements like Acetyl-L-carnitine (ALCAR) in managing symptoms of Long Covid and ME/CFS. Jamie, one of the panelists, shares anecdotal experiences with supplements such as CoQ10, DHA, and B vitamins, which have helped improve energy levels, cognitive function, and neurological issues. However, Jamie notes that these are not magic solutions and emphasizes the importance of individualized approaches and consulting healthcare professionals. Dr. Bateman and other panelists also discuss the safety and potential benefits of combining supplements like D-ribose, CoQ10, and L-carnitine to support ATP production, but stress that these observations are anecdotal and not definitive medical advice.
August 2020 • ME/CFS and Long COVID: What's the Connection?
What and who it targets
Fatigue-dominant patients
Addresses energy metabolism deficiencies.
Cognitive dysfunction sufferers
Improves memory and concentration issues.
Neurological symptom patients
Targets brain-related Long Covid symptoms.
Relevant research
How much evidence on this?
- Evidence spans multiple studies over 10 years.
- Research includes pilot studies and clinical trials.
- Studies focus on fatigue and mitochondrial dysfunction.
- Some findings suggest promising fatigue reduction.
Research focusing on
- May reduce fatigue and improve energy levels.
- Post-treatment care includes monitoring mitochondrial health.
- Compared to other supplements, effects are moderate.
- Researchers exploring neuroinflammation and serotonin links.
What needs more research?
- Long-term safety and efficacy unclear.
- Optimal dosage for long COVID not established.
- Mechanisms of action in long COVID remain uncertain.
- Interaction with other treatments needs study.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This paper explored the potential of acetyl-L-carnitine (ALCAR) as a treatment for neuropsychiatric symptoms of long COVID, such as fatigue, depression, and cognitive impairment. It compared long COVID with other fatigue-associated conditions like ME/CFS and reviewed molecular mechanisms related to acetylcarnitine metabolism.
The review found that acetyl-L-carnitine plays a role in regulating mitochondrial function, neuroinflammation, and energy production, which are disrupted in long COVID. It highlighted evidence from other conditions, such as ME/CFS and MDD, where acetyl-L-carnitine supplementation showed clinical benefits, suggesting its potential for long COVID treatment.
For individuals with long COVID, this paper suggests that acetyl-L-carnitine could be a promising supplement to address fatigue and cognitive issues. It provides hope for a treatment option that targets underlying biological processes rather than just symptoms.
As a literature review published in a reputable journal, this paper synthesizes existing research rather than presenting new experimental data. Its reliability depends on the quality of the studies reviewed, but it provides a strong conceptual foundation for further investigation.
January 2024 • European archives of psychiatry and clinical neuroscience
Research
This paper reviewed information about post-COVID syndrome, focusing on its causes and potential treatments. It also conducted a pilot observational study to test a food supplement containing acetyl L-carnitine, hydroxytyrosol, and vitamins B, C, and D for improving fatigue in patients recovering from COVID-19.
The study found that the food supplement showed promise in reducing perceived fatigue in patients with post-COVID syndrome. The authors suggested that the supplement could be further tested in clinical trials to confirm its effectiveness.
For individuals dealing with long COVID, this study offers hope that a combination of acetyl L-carnitine and other nutrients might help alleviate chronic fatigue. It suggests a potential pathway for improving quality of life through nutritional support.
As a pilot study, the findings are preliminary and need validation through larger clinical trials. The journal is reputable in the medical field, but the study's observational nature limits the strength of its conclusions.
December 2021 • European review for medical and pharmacological sciences
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Purchase online through platforms like Amazon or specialized supplement stores.
- Available in pharmacies as an over-the-counter supplement.
- Consultation with a healthcare provider is recommended for dosage and suitability.
Cost
- $30–$50 for a bottle of capsules (60–100 count) in the US.
- Prices vary slightly in other regions, with similar ranges in Europe and Canada.
- Bulk purchases may reduce per-unit costs.
Insurance cover
- Typically not covered by health insurance as it is classified as a dietary supplement.
- Coverage may vary by region; consult local insurance providers for details.
Locations
- Mayo Clinic Store offers Thorne Acetyl-L-Carnitine.
- Amazon provides multiple brands, including Swanson and Metabolic Maintenance.
- Pharmacies and health stores globally stock Acetyl-L-carnitine as a supplement.
Frequently asked questions
Key resources
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
